| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9343(99)80014-X |
| P698 | PubMed publication ID | 7778571 |
| P50 | author | Braxton D. Mitchell | Q30348346 |
| P2093 | author name string | R L Brey | |
| A Escalante | |||
| U Dreiner | |||
| P2860 | cites work | Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus | Q28261335 |
| Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus | Q28319260 | ||
| The meaning and use of the area under a receiver operating characteristic (ROC) curve | Q29547182 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Measuring the accuracy of diagnostic systems | Q29614441 | ||
| Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance | Q33392960 | ||
| Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients | Q33438663 | ||
| Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients | Q33447381 | ||
| Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus | Q33448275 | ||
| The diagnosis of strep throat in adults in the emergency room | Q34056346 | ||
| A method of comparing the areas under receiver operating characteristic curves derived from the same cases | Q34272510 | ||
| Signal detectability: the use of ROC curves and their analyses | Q37227801 | ||
| Integrating stratum-specific likelihood ratios with the analysis of ROC curves | Q40902299 | ||
| Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group | Q43654524 | ||
| Affirmative actions: can the discriminant accuracy of a test be determined in the face of selection bias? | Q52460041 | ||
| Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus | Q68008000 | ||
| Antiphospholipid antibodies and cerebral ischemia in young people | Q68347645 | ||
| Computed tomography versus ultrasound of the adrenal gland: a prospective study | Q70297553 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| antibody | Q79460 | ||
| lupus erythematosus | Q188297 | ||
| thrombosis | Q261327 | ||
| P304 | page(s) | 559-565 | |
| P577 | publication date | 1995-06-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus | |
| P478 | volume | 98 |
| Q41197401 | 1996 diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a "mission impossible'? |
| Q81201365 | A protocol for determination of anticardiolipin antibodies by ELISA |
| Q33328447 | Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards |
| Q43850415 | Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype |
| Q35099505 | Antiphospholipid syndrome: an overview. |
| Q36570675 | Autoantibody determination in the diagnosis of systemic lupus erythematosus |
| Q33404418 | Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays |
| Q33370780 | Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association? |
| Q35309576 | Detection of autoantibodies in a point-of-care rheumatology setting |
| Q52281870 | Detection of cerebral microembolic signals by transcranial Doppler may be a useful part of the equation in determining stroke risk in patients with antiphospholipid antibody syndrome. |
| Q36577371 | Diagnosis of antiphospholipid syndrome |
| Q33680556 | IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus |
| Q46318776 | IgA antiphospholipid antibodies are an independent risk factor for thromboses |
| Q37939730 | International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies |
| Q33329907 | Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype |
| Q36458164 | Laboratory diagnosis and management challenges in the antiphospholipid syndrome |
| Q36830770 | Neurological aspects of antiphospholipid antibody syndrome |
| Q59924786 | Neuropsychiatric systemic lupus erythematosus |
| Q52652019 | Performance Evaluation and Clinical Associations of Immunoassays That Detect Antibodies to Negatively Charged Phospholipids Other Than Cardiolipin. |
| Q43677862 | Prevalence and isotype distribution of antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus (SLE). |
| Q77391585 | Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients |
| Q33766710 | Testing for and clinical significance of anticardiolipin antibodies |
| Q38374306 | The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome |
| Q36229639 | The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies |
| Q24682977 | The use of laboratory tests in the diagnosis of SLE |
| Q37642828 | Thrombosis in systemic lupus erythematosus: risk and protection |
| Q41475203 | Thrombotic syndromes and autoimmune diseases |
| Q41197504 | Treatment of neurologic complications of antiphospholipid antibody syndrome |
| Q36709341 | Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus |
Search more.